Regulus Therapeutics Inc (RGLS) Directors and Executive Officers - CSIMarket
CSIMarket
 
Regulus Therapeutics Inc   (NASDAQ: RGLS)

Regulus Therapeutics Inc

Officers & Directors


Joseph P. Hagan
Chief Executive Officer - (Principal Executive Officer)

Preston Klassen, M.D.
Director -

Cris Calsada
Chief Financial Officer - (Principal Financial Officer)

Joseph P. Hagan
Chief Executive Officer and Director - (Principal Executive Officer)

Alice Huang, Ph.D.
Director -

Pascale Witz
Director -

Jake R. Nunn
Director -

Kathryn Collier
Director -

William H. Rastetter, Ph.D.
Director -

Stelios Papadopoulos, Ph.D.
Chairman of the Board of Directors -

David Baltimore, Ph.D.
Director -

Daniel J. Penksa
Vice President, - Finance

Hugh Rosen, M.D., Ph.D.
Director - ,

Regulus Therapeutics Inc currently has 34 employees.






RGLS Management Effectiveness RGLS Revenue per Employee RGLS Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.